Prescription for Change 2025

Page 23 of 28 · WEF_Prescription_for_Change_2025.pdf

Contributors Acknowledgements Irene Aninye Society for Women’s Health Research Diego Baptista Wellcome Trust Kihara Anne Beatrice The International Federation of Gynecology and Obstetrics (FIGO) Catharina Boehme World Health Organization Nicholas Brooke The Synergist Alejandra Cardenas Center for Reproductive Rights Alison Cave Medicine and Healthcare products Regulatory Agency (MHRA) UK Anna Coates World Health Organization Alysha Croker Health Canada Corinne de Vries European Medicines AgencyVictoria DiBiaso Sanofi Hema Divakar The International Federation of Gynecology and Obstetrics (FIGO) Victor Dzau National Academy of Medicine Christine Enciso Regeneron Marwan Fathallah Drug Information Association (DIA) Elizabeth Garner Women’s Health Access Matters Josette Gbemudu MSD Maya Goldstein Impact Global Health Christine Haenggeli Swiss Medic Shirin Heidari Gender, Evidence, and Health Network (GENDRO)World Economic Forum Shyam Bishen Head, Centre for Health and Healthcare; Member of the Executive Committee Anna Bode Project Fellow, Women’s Health Emily Fitzgerald Initiatives Lead, Women’s Health Amira Ghouaibi Head, Global Alliance for Women’s HealthThe Gates Foundation Sanjana Bhardwaj Deputy Director, Program Advocacy and Communications Kaitlin Christenson Senior Program Manager, Program Advocacy and Communications Kearney Paula Bellostas Muguerza Senior Partner, Global Lead, Healthcare and Life Sciences Science and Innovation Working GroupThis seminal work is a result of the collective expertise and invaluable contributions of the distinguished experts in the working groups, whose insights have been fundamental to its development. Prescription for Change: Policy Recommendations for Women’s Health Research 23
Ask AI what this page says about a topic: